FDA will periodically update a publicly available list of MUMS-designated drugs. This list will be placed on file at the FDA Division of Dockets Management, and will contain the following information for each MUMS-designated drug:
The name and address of the sponsor;
The established name and trade name, if any, of the drug;
The dosage form of the drug;
The species and the proposed intended use for which MUMS-drug designation was granted; and
The date designation was granted.